Literature DB >> 35780253

Peripherally inserted central venous catheters decrease central line-associated bloodstream infections and change microbiological epidemiology in adult hematology unit: a propensity score-adjusted analysis.

Yosuke Nakaya1,2, Mika Imasaki3, Michinori Shirano4, Katsujun Shimizu1, Naoko Yagi1, Minako Tsutsumi1,2, Masahiro Yoshida1, Takuro Yoshimura1, Yoshiki Hayashi1, Takafumi Nakao1, Takahisa Yamane1.   

Abstract

Peripherally inserted central venous catheters (PICCs) have a potential advantage in preventing central line-associated bloodstream infection (CLABSI) compared with the centrally inserted ones (CICCs). However, due to a limited number of studies with insufficient statistical evaluation, the superiority of PICCs is difficult to be generalized in adult hematology unit. We conducted a single-center retrospective study and compared the risk of CLABSI between 472 CICCs and 557 PICCs inserted in adult patients with hematological disorders through conventional multivariate models and a propensity score-adjusted analysis. The overall CLABSI incidence in CICCs and PICCs was 5.11 and 3.29 per 1000 catheter days (P = 0.024). The multivariate Cox regression analysis (hazard ratio [HR]: 0.48; 95% confidence interval [CI]: 0.31-0.75; P = 0.001) and Fine-Gray subdistribution analysis (HR: 0.59; 95% CI: 0.37-0.93; P = 0.023) demonstrated that PICC was independently associated with a reduced risk of CLABSI. Moreover, the stabilized inverse probability of treatment weighting analysis, which further reduced the selection bias between CICCs and PICCs, showed that PICCs significantly prevented CLABSI (HR: 0.58; 95% CI: 0.35-0.94; P = 0.029). Microbiologically, PICCs showed a significant decrease in gram-positive cocci (P = 0.001) and an increase in gram-positive bacilli (P = 0.002) because of a remarkable reduction in Staphylococci and increase in Corynebacterium species responsible for CLABSI. Our study confirmed that PICC was a superior alternative to CICC in preventing CLABSI in the adult hematology unit, while it posed a microbiological shift in local epidemiology.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Central line-associated bloodstream infection; Corynebacterium; Hematological disorder; Inverse probability of treatment weighting; Peripherally inserted central venous catheter; Propensity score

Mesh:

Year:  2022        PMID: 35780253     DOI: 10.1007/s00277-022-04908-6

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   4.030


  39 in total

Review 1.  Systematic review of economic analyses of health care-associated infections.

Authors:  Patricia W Stone; Deborah Braccia; Elaine Larson
Journal:  Am J Infect Control       Date:  2005-11       Impact factor: 2.918

Review 2.  The risk of bloodstream infection associated with peripherally inserted central catheters compared with central venous catheters in adults: a systematic review and meta-analysis.

Authors:  Vineet Chopra; John C O'Horo; Mary A M Rogers; Dennis G Maki; Nasia Safdar
Journal:  Infect Control Hosp Epidemiol       Date:  2013-07-26       Impact factor: 3.254

3.  A role for peripherally inserted central venous catheters in the prevention of catheter-related blood stream infections in patients with hematological malignancies.

Authors:  Toshiro Sakai; Kyuhei Kohda; Yuichi Konuma; Yasuko Hiraoka; Yukari Ichikawa; Kaoru Ono; Hiroto Horiguchi; Ayumi Tatekoshi; Kouichi Takada; Satoshi Iyama; Junji Kato
Journal:  Int J Hematol       Date:  2014-09-24       Impact factor: 2.490

4.  Clinical management of peripherally inserted central catheters compared to conventional central venous catheters in patients with hematological malignancies: A large multicenter study of the REL GROUP (Rete Ematologica Lombarda - Lombardy Hematologic Network, Italy).

Authors:  Nicola Stefano Fracchiolla; Elisabetta Todisco; Andrea Bilancia; Sara Gandolfi; Nicola Orofino; Francesca Guidotti; Valentina Mancini; Laura Marbello; Andrea Assanelli; Massimo Bernardi; Armando Santoro; Roberto Cairoli; Dario Consonni; Agostino Cortelezzi
Journal:  Am J Hematol       Date:  2017-10-10       Impact factor: 10.047

5.  Catheter-associated bloodstream infection incidence and risk factors in adults with cancer: a prospective cohort study.

Authors:  P Mollee; M Jones; J Stackelroth; R van Kuilenburg; W Joubert; J Faoagali; D Looke; J Harper; A Clements
Journal:  J Hosp Infect       Date:  2011-04-02       Impact factor: 3.926

6.  Clinical and economic outcomes in critically ill patients with nosocomial catheter-related bloodstream infections.

Authors:  Stijn I Blot; Pieter Depuydt; Lieven Annemans; Dominique Benoit; Eric Hoste; Jan J De Waele; Johan Decruyenaere; Dirk Vogelaers; Francis Colardyn; Koenraad H Vandewoude
Journal:  Clin Infect Dis       Date:  2005-10-25       Impact factor: 9.079

7.  Attributable cost and length of stay for patients with central venous catheter-associated bloodstream infection in Mexico City intensive care units: a prospective, matched analysis.

Authors:  Francisco Higuera; Manuel Sigfrido Rangel-Frausto; Victor Daniel Rosenthal; Jose Martinez Soto; Jorge Castañon; Guillermo Franco; Natividad Tabal-Galan; Javier Ruiz; Pablo Duarte; Nicholas Graves
Journal:  Infect Control Hosp Epidemiol       Date:  2007-01       Impact factor: 3.254

8.  A Frontline Approach With Peripherally Inserted Versus Centrally Inserted Central Venous Catheters for Remission Induction Chemotherapy Phase of Acute Myeloid Leukemia: A Randomized Comparison.

Authors:  Marco Picardi; Roberta Della Pepa; Claudio Cerchione; Novella Pugliese; Chiara Mortaruolo; Fabio Trastulli; Claudia Giordano; Francesco Grimaldi; Irene Zacheo; Marta Raimondo; Federico Chiurazzi; Fabrizio Pane
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2018-12-20

9.  Prevalence and predictors of peripherally inserted central catheter-associated bloodstream infections in adults: A multicenter cohort study.

Authors:  Jae Hwan Lee; Eung Tae Kim; Dong Jae Shim; Il Jung Kim; Jong Hyun Byeon; In Joon Lee; Hyun Beom Kim; Young Ju Choi; Jin Hong Lee
Journal:  PLoS One       Date:  2019-03-07       Impact factor: 3.240

10.  Incidence, risk factors and healthcare costs of central line-associated nosocomial bloodstream infections in hematologic and oncologic patients.

Authors:  Claas Baier; Lena Linke; Matthias Eder; Frank Schwab; Iris Freya Chaberny; Ralf-Peter Vonberg; Ella Ebadi
Journal:  PLoS One       Date:  2020-01-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.